Bifidobacterium infantis 4 mg Oral Capsule
RxNorm 795705

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 795705 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Bifidobacterium infantis 4 mg Oral Capsule.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Bifidobacterium infantis 4 mg Oral Capsule
Primary clinical definition
AUI:12776539
View
PSN
Bifidobacterium infantis 4 mg Oral Capsule
AUI:6367400
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
Bifidobacterium infantis 4 mg Oral Capsule
(Atom ID: 12776539)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Bifidobacterium infantis 4 MG Oral Capsule
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
795705
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12776539
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
795705
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2618894} 100213
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2618894} 100213
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
4 MG
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{2618894} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXTERM FORM
Cap
The RxTerm dose form name for this drug
PSNPrescribable

Prescribable Name (PSN):
Bifidobacterium infantis 4 mg Oral Capsule
(Atom ID: 6367400)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Bifidobacterium infantis 4 MG Oral Capsule
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
795705
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6367400
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
795705
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Bifidobacteria


What is it? Bifidobacteria species are probiotics ("good" bacteria) that live in the intestines. They may help with diarrhea, constipation, and other intestinal disorders.

"Good" bacteria such as bifidobacteria can help break down food, absorb nutrients, and fight off "bad" organisms that might cause diseases.

Bifidobacteria are commonly used for diarrhea, constipation, and irritable bowel syndrome (IBS). They're also used for preventing the common cold or flu, and lots of other conditions, but there is no good scientific evidence to support many of these uses. There is also no good evidence to support using bifidobacteria for COVID-19.
[Learn More]


* Please review the disclaimer below.